Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FOXA stock price vs ECL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ECL's multiple
Needs ECL P/E.
Implied fair value · at FOXA's multiple
Needs FOXA P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Fox Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ECOLAB INC. · implied price per share
Bear
$44.93
Base
$57.49
Bull
$73.86
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Sinclair, Inc.
FOXA vs SBGI
TEGNA INC
FOXA vs TGNA
COMCAST CORP
FOXA vs CMCSA
Walt Disney Co
FOXA vs DIS
Warner Bros. Discovery, Inc.
FOXA vs WBD
Paramount Global
FOXA vs PARA
Procter & Gamble Company
FOXA vs PG
COLGATE PALMOLIVE CO
FOXA vs CL
CLOROX CO /DE/
FOXA vs CLX
KIMBERLY CLARK CORP
FOXA vs KMB
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe FOXA can sustain its 16.6% revenue growth without a material step-down in margins, then FOXA looks attractive on valuation and may merit ownership; otherwise, the current discount may simply reflect lower business quality versus ECL.
FOXA trades at a steep valuation discount to ECL, with a 12.0x P/E versus 38.1x for ECL and much lower EV/EBITDA and EV/Revenue multiples. The market is effectively paying far less for FOXA’s earnings and sales, but the gap is large enough that it likely reflects differences in business quality and durability.
Supporting Metrics
